Category: Research & Clinical Trials

Researchers at Brigham and Women’s Hospital are trying to answer that question so they can extend survival for all mesothelioma patients.

The U.S. Department of Defense multiyear grants will advance mesothelioma research at the University of Hawaii Cancer Center.

Researchers are hopeful the immunotherapy vaccine will be the first to provide treatment for mesothelioma when standard therapies fail.

Baylor College of Medicine in Houston began enrolling participants for the mesothelioma surgery and immunotherapy clinical trial last week.

Mesothelioma specialist Dr. Dan Sterman says the clinical trial promises to extend patients’ lives and improve their quality of life.

Mesothelioma specialist Dr. David Sugarbaker of Baylor College of Medicine says discovery is a home run in mesothelioma treatment.

New clinical trials focusing on chemoperfusion and antibody treatments show promise for mesothelioma patients.

Researchers halted the tremelimumab clinical trial because the immunotherapy drug didn’t benefit mesothelioma patients.

NIOSH has renewed grant funding for the National Mesothelioma Virtual Bank, giving researchers access to tissue samples and data crucial to research.

Several leading cancer centers across the U.S. are offering a mesothelioma clinical trial for TRC102, a novel drug that may improve chemotherapy.

Study of nearly 15,000 mesothelioma patients shows surgery remains an effective measure that extends survival.

Those seeking more research about lung cancer can follow the lead of those who championed against breast cancer.

Defactinib’s poor performance in targeting pleural mesothelioma stem cells forced researchers to stop enrolling people for the trial.

The Jarvis family lost their patriarch to mesothelioma, and now they’re helping the Pacific Meso Center raise money to find a cure for the asbestos disease.

Researchers say traits in mesothelioma patients under age 40 could lead researchers to better understand the asbestos-related cancer.